22 | | - | than January 1, 2022, that would be (1) funded by enrollee premiums, 5 |
---|
23 | | - | and (2) open to individuals ineligible for Medicaid who earn less than 6 |
---|
24 | | - | four hundred per cent of the federal poverty level. The working group 7 |
---|
25 | | - | shall study how best to expand consumer choice and improve the 8 |
---|
26 | | - | viability and affordability of the private insurance marketplace. 9 |
---|
27 | | - | (b) In addition to the executive director of the Office of Health 10 |
---|
28 | | - | Strategy, the working group shall include, but need not be limited to: 11 |
---|
29 | | - | (1) Three consumer advocates, one each appointed by the speaker, 12 |
---|
30 | | - | the majority leader and the minority leader of the House of 13 |
---|
31 | | - | Representatives; 14 |
---|
32 | | - | (2) Three providers, including at least one private insurance 15 |
---|
33 | | - | provider and one Medicaid-enrolled health care provider, one each 16 |
---|
34 | | - | appointed by the president pro tempore, the majority leader and the 17 |
---|
35 | | - | minority leader of the Senate; 18 Substitute Bill No. 7339 |
---|
| 28 | + | than January 1, 2021, that would be funded by enrollee premiums and 5 |
---|
| 29 | + | open to individuals ineligible for Medicaid. In addition, the working 6 |
---|
| 30 | + | group shall study how best to expand consumer choice and improve 7 |
---|
| 31 | + | the viability and affordability of the private insurance marketplace. 8 |
---|
| 32 | + | (b) The working group shall include: (1) The State Comptroller; (2) 9 |
---|
| 33 | + | the Commissioner of Social Services, or the commissioner's designee; 10 |
---|
| 34 | + | (3) the Insurance Commissioner, or the commissioner's designee; (4) 11 |
---|
| 35 | + | the Healthcare Advocate, or the Healthcare Advocate's designee; (5) a 12 |
---|
| 36 | + | representative of the Connecticut Health Insurance Exchange, 13 |
---|
| 37 | + | appointed by the chairperson of the board; (6) representatives of health 14 |
---|
| 38 | + | care providers, including Medicaid providers; (7) health care 15 |
---|
| 39 | + | consumers, including Medicaid recipients; (8) health insurance plans; 16 Raised Bill No. 7339 |
---|
42 | | - | (3) The Commissioner of Social Services, or the commissioner's 19 |
---|
43 | | - | designee; 20 |
---|
44 | | - | (4) The State Comptroller, or the State Comptroller's designee; 21 |
---|
45 | | - | (5) The Healthcare Advocate appointed pursuant to section 38a-1042 22 |
---|
46 | | - | of the general statutes, or the Healthcare Advocate's designee; and 23 |
---|
47 | | - | (6) Other stakeholders as deemed appropriate and appointed by the 24 |
---|
48 | | - | executive director of the Office of Health Strategy, including, but not 25 |
---|
49 | | - | limited to, (A) representatives of small businesses and employee 26 |
---|
50 | | - | groups, (B) behavioral health providers, (C) representatives of groups 27 |
---|
51 | | - | who have faced historical barriers to accessing healthcare, and (D) 28 |
---|
52 | | - | representatives of state agencies. 29 |
---|
53 | | - | (c) The executive director of the Office of Health Strategy shall serve 30 |
---|
54 | | - | as chairperson of the working group, which shall provide 31 |
---|
55 | | - | opportunities for stakeholder input prior to submitting its 32 |
---|
56 | | - | recommendations. The working group shall: 33 |
---|
57 | | - | (1) Evaluate how best to establish a public coverage option for 34 |
---|
58 | | - | persons not otherwise eligible for Medicaid pursuant to the HUSKY 35 |
---|
59 | | - | Health program, as defined in section 17b-290 of the general statutes; 36 |
---|
60 | | - | (2) (A) Evaluate whether the coverage option should be jointly 37 |
---|
61 | | - | administered with the Medicaid program or another existing program, 38 |
---|
62 | | - | and (B) if the coverage option is jointly administered with the 39 |
---|
63 | | - | Medicaid program, recommend how to ensure that the existing 40 |
---|
64 | | - | Medicaid program will not move to a managed care model and that 41 |
---|
65 | | - | existing enrollees will not experience reduction to their eligibility and 42 |
---|
66 | | - | benefits as a result of the new program's implementation; 43 |
---|
67 | | - | (3) Identify (A) the appropriate state agency or other public or 44 |
---|
68 | | - | private entity to administer such program, and (B) consumer 45 |
---|
69 | | - | protections that should be included in any applicable contract; 46 |
---|
70 | | - | (4) Formulate a plan design that includes the ten essential benefits 47 Substitute Bill No. 7339 |
---|
| 43 | + | LCO No. 5438 2 of 3 |
---|
| 44 | + | |
---|
| 45 | + | (9) small businesses and employee groups, appointed by the executive 17 |
---|
| 46 | + | director of the Office of Health Strategy; and (10) representatives of 18 |
---|
| 47 | + | other state agencies and industries as deemed appropriate by the 19 |
---|
| 48 | + | executive director of the Office of Health Strategy. 20 |
---|
| 49 | + | (c) The Office of Health Strategy shall provide administrative 21 |
---|
| 50 | + | support to the working group and may seek grants to support the 22 |
---|
| 51 | + | study. The working group shall provide opportunities for stakeholder 23 |
---|
| 52 | + | input prior to submitting its recommendations. The working group 24 |
---|
| 53 | + | shall: 25 |
---|
| 54 | + | (1) Evaluate how best to establish a public coverage option for 26 |
---|
| 55 | + | persons not otherwise eligible for Medicaid pursuant to the HUSKY 27 |
---|
| 56 | + | Health plan, as defined in section 17b-290 of the general statutes; 28 |
---|
| 57 | + | (2) Evaluate whether the coverage option should be jointly 29 |
---|
| 58 | + | administered with the Medicaid program or another existing program; 30 |
---|
| 59 | + | (3) Identify the appropriate state agency or other public or private 31 |
---|
| 60 | + | entity to administer such program and consumer protections that 32 |
---|
| 61 | + | should be included in any applicable contract; 33 |
---|
| 62 | + | (4) Formulate a plan design that includes the ten essential benefits 34 |
---|
| 63 | + | required pursuant to 42 USC 18022 and that is funded by premiums 35 |
---|
| 64 | + | assessed on enrollees, and, if approved by the federal government, 36 |
---|
| 65 | + | federal premium tax credits and cost-sharing subsidies; 37 |
---|
| 66 | + | (5) Consider how to attract and maintain provider participation and 38 |
---|
| 67 | + | set adequate provider payment rates; 39 |
---|
| 68 | + | (6) Review, if the program is modeled on the existing Medicaid 40 |
---|
| 69 | + | program, protections for existing Medicaid recipients; 41 |
---|
| 70 | + | (7) Consider how to mitigate potential adverse selection or risk 42 |
---|
| 71 | + | segmentation; 43 |
---|
| 72 | + | (8) Evaluate whether and how to include components of the person-44 |
---|
| 73 | + | centered medical home, value-based insurance design or similar 45 Raised Bill No. 7339 |
---|
77 | | - | required pursuant to 42 USC 18022 and that is funded by premiums 48 |
---|
78 | | - | assessed on enrollees, and, if approved by the federal government, 49 |
---|
79 | | - | federal premium tax credits and cost-sharing subsidies; 50 |
---|
80 | | - | (5) Consider how to attract and maintain provider participation and 51 |
---|
81 | | - | set adequate provider payment rates; 52 |
---|
82 | | - | (6) Consider how to mitigate potential adverse selection or risk 53 |
---|
83 | | - | segmentation; 54 |
---|
84 | | - | (7) Evaluate whether and how to include components of the person-55 |
---|
85 | | - | centered medical home, value-based insurance design or similar 56 |
---|
86 | | - | models; 57 |
---|
87 | | - | (8) Evaluate whether the state should apply for a state innovation 58 |
---|
88 | | - | waiver under 42 USC 18052 to allow eligible persons who enroll in the 59 |
---|
89 | | - | plan to use tax credits and cost-sharing subsidies toward their 60 |
---|
90 | | - | premiums; and 61 |
---|
91 | | - | (9) Advise on how to leverage, preserve or maximize federal dollars 62 |
---|
92 | | - | available to Connecticut consumers, companies or other entities. 63 |
---|
93 | | - | (d) The Office of Health Strategy shall provide administrative 64 |
---|
94 | | - | support to the working group and may seek grants to support the 65 |
---|
95 | | - | study. 66 |
---|
96 | | - | (e) The executive director of the Office of Health Strategy may issue 67 |
---|
97 | | - | interim reports and findings relating to the study as the executive 68 |
---|
98 | | - | director deems appropriate to the Health Care Cabinet established 69 |
---|
99 | | - | pursuant to section 19a-725 of the general statutes and legislative 70 |
---|
100 | | - | committees of cognizance. 71 |
---|
101 | | - | (f) Not later than February 15, 2021, the executive director of the 72 |
---|
102 | | - | Office of Health Strategy shall submit a report, in accordance with the 73 |
---|
103 | | - | provisions of section 11-4a of the general statutes, on the results of the 74 |
---|
104 | | - | study required pursuant to this section to the joint standing 75 |
---|
105 | | - | committees of the General Assembly having cognizance of matters 76 Substitute Bill No. 7339 |
---|
| 77 | + | LCO No. 5438 3 of 3 |
---|
107 | | - | |
---|
108 | | - | LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07339- |
---|
109 | | - | R01-HB.docx } |
---|
110 | | - | 4 of 4 |
---|
111 | | - | |
---|
112 | | - | relating to appropriations and the budgets of state agencies, human 77 |
---|
113 | | - | services and insurance. The report shall include an actuarial and 78 |
---|
114 | | - | economic analysis of the public health insurance coverage option. 79 |
---|
| 79 | + | models; 46 |
---|
| 80 | + | (9) Evaluate whether the state shall apply for a state innovation 47 |
---|
| 81 | + | waiver under 42 USC 18052 to allow eligible persons who enroll in the 48 |
---|
| 82 | + | plan to use tax credits and cost-sharing subsidies toward their 49 |
---|
| 83 | + | premiums; and 50 |
---|
| 84 | + | (10) Advise on how to leverage, preserve or maximize federal 51 |
---|
| 85 | + | dollars available to Connecticut consumers, companies or other 52 |
---|
| 86 | + | entities. 53 |
---|
| 87 | + | (d) The executive director of the Office of Health Strategy may issue 54 |
---|
| 88 | + | interim reports and findings relating to the study as the executive 55 |
---|
| 89 | + | director deems appropriate to the Health Care Cabinet and legislative 56 |
---|
| 90 | + | committees of cognizance. 57 |
---|
| 91 | + | (e) Not later than February 15, 2020, the executive director of the 58 |
---|
| 92 | + | Office of Health Strategy shall submit a report, in accordance with the 59 |
---|
| 93 | + | provisions of section 11-4a of the general statutes, on the results of the 60 |
---|
| 94 | + | study required pursuant to this section to the joint standing 61 |
---|
| 95 | + | committees of the General Assembly having cognizance of matters 62 |
---|
| 96 | + | relating to appropriations and the budgets of state agencies, human 63 |
---|
| 97 | + | services and insurance. The report shall include an actuarial and 64 |
---|
| 98 | + | economic analysis of the public health insurance coverage option. 65 |
---|